The Oncology Institute, Inc.

NASDAQ:TOI

Medical - Care Facilities

Healthcare
$5.13 -1.40%

-$0.07 today

Market cap
$512.91M
Beta
0.41
P/E (TTM)
-121.1
EPS (TTM)
-$0.04
52W Low $2.02High $5.58

Volume 1.21M

Average 1.74M

TOI Interest Expense

Cost of servicing the company's debt during the period.

The Oncology Institute, Inc.NASDAQ: TOI

Interest Expense · Q1 FY2026 · quarter ended Mar 2026

Interest expense declines year over year

Q1 FY2026 interest expense of $1.93M fell 65.3% year over year, behind the -31.1% change in trailing-twelve-month interest expense. Sequentially, it rose 0.9% from the prior quarter. Over 3 fiscal years it compounded at +40.3% a year.

Context

  • Interest expense amounted to 2.2% of revenue in FY2025, up 0.3 pp from a year earlier.
  • Interest expense increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -65.3% toward the trailing-twelve-month pace of -31.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.93M+0.9% QoQ
Last fiscal yearDec 2025
$11.28M+50.4% YoY
LTMMar 2026
$7.64M-31.1% YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-65.3%——
1 year+50.4%——
3-year CAGR+40.3%——
5-year CAGR——
10-year CAGR——

Interest Expense history

USD · from the income statement

Latest · FY2025
11.28M USD
Year-over-year change
+50.4%
4-year CAGR
+143.6%

Interest Expense vs competitors

How TOI compares with its peers on the latest reported figures

  • Peers report in different currencies, so interest expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -31.1% is the 8th highest of 10, against a peer median of +4.4%.
  • Interest expense amounts to 1.4% of revenue for TOI, versus a peer median of 2.9%.
TOI Competitors
Interest Expense for TOI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AUNAAuna S.A.LTM Mar 2026PEN 409.67M PEN-12.6%+27.8%9.1%
AUTLAutolus Therapeutics plcLTM Mar 2026$44.43M USD+26345.5%+60.4%48.0%
SNDASonida Senior Living, Inc.FY2025$38.64M USD+4.4%+5.4%10.1%
EOLSEvolus, Inc.LTM Mar 2026$19.25M USD+4.4%+29.4%6.4%
TOIThe Oncology Institute, Inc.LTM Mar 2026$7.64M USD-31.1%+40.3%1.4%
KIDSOrthoPediatrics Corp.LTM Mar 2026$6.97M USD+124.2%+35.2%2.9%
TMCITreace Medical Concepts, Inc.LTM Mar 2026$5.58M USD+6.3%+6.5%2.7%
AGLAgilon Health, Inc.LTM Mar 2026$3.32M USD-48.3%+14.0%0.1%
CCRNCross Country Healthcare, Inc.LTM Mar 2026$2.24M USD-1.3%-46.4%0.2%
CBLLCeriBell, Inc.LTM Mar 2026$985K USD-50.3%+5.6%1.0%
Peer median (excluding TOI) —+4.4%+14.0%2.9%

Competitors are the stored peer set for TOI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue203M252.48M324.24M393.41M502.73M
Cost of Revenue162.16M200.39M264.67M339.42M426.29M
Gross Profit40.85M52.09M59.57M54M76.44M
Gross Margin20.1%20.6%18.4%13.7%15.2%
Research & Development00000
Selling, General & Admin0000105.57M
Operating Expenses86.71M134.04M136.59M114.12M112.52M
Depreciation & Amortization3.34M4.41M5.87M6.29M6.94M
EBITDA(42.04M)(67.6M)(54.28M)(50.88M)(42.52M)
EBITDA Margin-20.7%-26.8%-16.7%-12.9%-8.5%
Operating Income(45.86M)(81.95M)(77.02M)(60.12M)(36.08M)
Operating Margin-22.6%-32.5%-23.8%-15.3%-7.2%
Interest Income00000
Interest Expense320K4.08M6.78M7.5M11.28M
Other Income / Expenses34.26M81.86M(6.09M)(4.55M)(24.65M)
Income Before Tax(11.6M)(91K)(83.1M)(64.66M)(60.74M)
Pre-Tax Margin-5.7%-0.0%-25.6%-16.4%-12.1%
Income Tax Expense(671K)(243K)(36K)0(131K)
Net Income(10.93M)152K(83.07M)(64.66M)(60.61M)
Net Margin-5.4%0.1%-25.6%-16.4%-12.1%
EPS (Basic)(0.16)0.00(0.92)(0.71)(0.54)
EPS (Diluted)(0.16)(0.21)(0.92)(0.71)(0.54)
Weighted Avg Shares66.23M72.79M73.75M75.04M923.89M
Weighted Avg Shares (Diluted)66.23M80.61M73.75M75.04M923.89M

The Oncology Institute, Inc.

NASDAQ:TOI

Intrinsic Alpha fair value

Locked

Current Price

$5.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.